BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Cantor Fitzgerald
Baxter
UBS
Fish and Richardson
Cerilliant
US Department of Justice
Citi
Julphar

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,820,186

« Back to Dashboard

Which drugs does patent 7,820,186 protect, and when does it expire?

Patent 7,820,186 protects EPIDUO and is included in one NDA.

This patent has thirty patent family members in twenty-two countries.
Summary for Patent: 7,820,186
Title:Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Abstract:Dermatological/cosmetic gel compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise (i) at least one retinoid, (ii) dispersed benzoyl peroxide and (iii) at least one pH-independent gelling agent, formulated into (iv) a physiologically acceptable medium therefor.
Inventor(s): Orsoni; Sandrine (Mandelieu, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma Research & Development (FR)
Application Number:10/326,389
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 7,820,186

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,820,186

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France01 16747Dec 21, 2001

Non-Orange Book US Patents Family Members for Patent 7,820,186

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,814,690 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt ➤ Subscribe
7,964,202 Method for treatment of common acne ➤ Subscribe
8,105,618 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide ➤ Subscribe
8,936,800 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt ➤ Subscribe
8,241,649 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,820,186

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1607946 ➤ Subscribe
Brazil PI0214264 ➤ Subscribe
Canada 2466321 ➤ Subscribe
China 1329025 ➤ Subscribe
Cyprus 1107583 ➤ Subscribe
Germany 60216634 ➤ Subscribe
Hungary 0500006 ➤ Subscribe
Germany 122008000041 ➤ Subscribe
Denmark 1458369 ➤ Subscribe
European Patent Office 1458369 ➤ Subscribe CA 2008 00029 Denmark ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
QuintilesIMS
UBS
Colorcon
Moodys
Farmers Insurance
Novartis
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot